Chemotherapy-induced peripheral neuropathy

Newsletter # 69

Cellular models

Chemotherapy-induced peripheral neuropathy (CIPN) is a common negative side effect that limits the use of neurotoxic chemotherapy agents such as Taxol, Vincristine and Cisplatin. The development of innovative therapies that can protect the peripheral nerves without impairing the action of the chemotherapy agent is among one of the latest strategies in the market to tackle CIPN.


NEUROFIT has developed a relevant in-vitro model system that reproduces CIPN and allows us to fully evaluate, measure and analyse the beneficial action of your test compounds.
:



NEUROFIT offers a range of validated in vitro and in vivo screening tests for psychiatry and neurology.

If you need further information, please do not hesitate to contact us. Privacy Policy
On a regular basis we distribute newsletters with scientific information on our research services. If you wish to receive these, please sign up on our mailing list: